Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. (KDNY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KDNY · as of Jun 8, 2026
Key Statistics
Explore Chinook Therapeutics, Inc. Data
kdny stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 18.2%
The KDNY analyst consensus is Hold, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $30.00, representing -25.72% downside from the current price of $40.39.
Competitors & Peers
kdny competitorsKDNY
BLU
CALT
DICE
FUSN
LBPHStock Performance
Full HistoryAbout Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kid…
what is chinook therapeutics, inc. · kdny stock overview · chinook therapeutics, inc. company profile · who is chinook therapeutics, inc. ceo · kdny NASDAQ · chinook therapeutics, inc. headquarters · chinook therapeutics, inc. business segments
About Stock Overview & Key Data
Chinook Therapeutics, Inc. (KDNY) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 6, 2020. As of the latest trading session, KDNY stock price is $40.39, with a market capitalization of $2.7B. The stock has returned +76.76% over the past 12 months and +58.77% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Chinook Therapeutics, Inc. stock is Hold, with an average 12-month price target of $30.00. In fiscal year 2022, Chinook Therapeutics, Inc. reported revenue of $6.1M and net income of -$184.6M. For detailed data — including Chinook Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Chinook Therapeutics, Inc. (KDNY) stock price is $40.39. The stock is traded on NASDAQ under the ticker symbol KDNY. The 52-week range is $18.34 – $40.51.